Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Teijin expands overseas to support development of TEI-6720

June 5, 1998

Fujisawa compounds lower blood cholesterol, triglyceride and lipid levels

June 5, 1998

Fenofibrate capsules now available in U.S.

June 5, 1998

80-90% response rate obtained with Topiglan

June 4, 1998

More sildenafil clinical data presented at AUA; CPMP recommends European marketing approval

June 4, 1998

Harvard Scientific begins phase II trial with erectile dysfunction product

June 4, 1998

Transurethral alprostadil: conflicting results presented at AUA meeting

June 3, 1998

Vasomax phase III results presented at AUA meeting

June 3, 1998

Prandin introduced for treatment of type II diabetes in U.S.

June 3, 1998

Novartis files for U.S. marketing approval of Sandostatin LAR

June 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...